Summary

for people ages 18 years and up (full criteria)
at UCLA
study started
estimated completion:
Jaime Deville (ucla)

Description

Summary

This is a prospective cohort study designed to define the impact of HIV infection and antiretroviral therapy (ART) on young adults with perinatal HIV infection as they transition to adulthood.

Official Title

Adolescent Master Protocol for Participants 18 Years of Age or Older - Lite (AMP Up Lite)

Details

This is a prospective cohort study designed to define the impact of HIV infection and antiretroviral therapy (ART) on young adults with perinatal HIV infection as they transition to adulthood.

The primary objectives of this study are:

  1. To identify infectious and non-infectious complications of HIV disease and toxicities resulting from long-term ART, including disease progression, immune suppression, viral resistance, end-organ disease, and mortality.
  2. To define the impact of HIV infection and ART on the long-term clinical outcomes of young adults with perinatal HIV.
  3. To define the impact of perinatal HIV infection and ART on long-term mental and behavioral health outcomes.

Keywords

HIV/AIDS HIV/AIDS, perinatal HIV infection

Eligibility

You can join if…

Open to people ages 18 years and up

  • Perinatal HIV infection as documented in the medical record;
  • At or beyond their 18th birthday at the time of informed consent with no upper age limit;
  • Willingness to provide access to existing medical records; and
  • Willingness to participate and provide legal consent

You CAN'T join if...

  • Prisoner status

Locations

  • David Geffen School of Medicine at UCLA accepting new patients
    Los Angeles California 90095 United States
  • University of Southern California accepting new patients
    Los Angeles California 90033 United States

Lead Scientist

  • Jaime Deville (ucla)
    Health Sciences Clinical Professor, Pediatric Infectious Diseases. Authored (or co-authored) 39 research publications

Details

Status
accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
Harvard School of Public Health
Links
Pediatric HIV/AIDS Cohort Study
ID
NCT03279185
Study Type
Observational
Last Updated